Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.
第一作者:
Michael,Back
第一单位:
Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.;Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.;Genesis Cancer Care, Sydney, New South Wales, Australia.;Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.;The Brain Cancer Group, Sydney, New South Wales, Australia.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);脑肿瘤(Brain Neoplasms);综合疗法(Combined Modality Therapy);造影剂(Contrast Media);颅骨切开术(Craniotomy);女(雌)性(Female);神经胶质瘤(Glioma);人类(Humans);磁共振成像(Magnetic Resonance Imaging);男(雄)性(Male);中年人(Middle Aged);放射疗法, 调强适形(Radiotherapy, Intensity-Modulated);存活率(Survival Rate);治疗结果(Treatment Outcome)
DOI
10.1111/1754-9485.12850
PMID
30677248
发布时间
2019-08-12
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



